Skip to main content

Research at UNC Children's


Browse funding opportunities
  • 12 Months of Treatment with EPIT Superior to Placebo in Desensitizing Children to Peanuts

    The study, called EPITOPE, led by senior author A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, and contributing author Edwin Kim, MD, MS, associate professor of pediatrics in the Division of Pediatric Allergy and Immunology at the UNC School of Medicine, shows superior results in desensitizing children … Continued

  • Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease

    Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication. CHAPEL HILL, N.C. – Crohn’s disease is a lifelong inflammatory bowel disease (IBD) that is … Continued

  • Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

    A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children. A four-year phase 2 clinical trial demonstrated that a peanut allergy treatment called sublingual immunotherapy, or SLIT, is effective and … Continued

  • Ian Davis Awarded $1 Million by V Foundation

    The V Foundation Board of Directors and Scientific Advisory Board has awarded funding to Ian Davis, MD, PhD, the G. Denman Hammond Professor of Childhood Cancer in the Division of Hematology/Oncology and a UNC Lineberger Comprehensive Cancer Center member, for his research project, “Novel mechanisms to improve CAR-T cell therapy for pediatric solid tumors”. The award is being … Continued

View All News